StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
FLSCFrazier Life Sciences Acquisition Corp. II
stockpulse.co.kr
Nasdaq
$10.29▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

8
  • 2d agoAfter-hours26.10.23 06:24
    8-KKey event#●●●#●●●#●●●

    Frazier Life Sciences Acquisition Corp. II

    Frazier Life Sciences Acquisition Corp. II completed its initial public offering (IPO) on October 15, 2026, issuing 7.5 million Class A ordinary shares at $10.00 per share to raise $75 million in gross proceeds. Simultaneously, the company raised an additional $3 million through a private placement to its sponsor, with the total proceeds held in a trust account for future business combinations.…more

    $10.29+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 2d agoAfter-hours26.10.23 05:07
    SCHEDULE 13GOwnership

    Frazier Life Sciences Acquisition Corp. II

    RA Capital Management, L.P. and associated parties entered into a Joint Filing Agreement on October 22, 2026, regarding the beneficial ownership of Class A ordinary shares of Frazier Life Sciences Acquisition Corp. II. This agreement establishes the framework for filing a single Schedule 13G/13D statement on behalf of all involved parties.…more

    $10.29+0.00%vs prev close
    View filingShare
  • 3d agoAfter-hours26.10.22 06:37
    SCHEDULE 13DOwnership

    Frazier Life Sciences Acquisition Corp. II

    Frazier Life Sciences Holdings II LLC has filed a SCHEDULE 13D to report its beneficial ownership stake in Frazier Life Sciences Acquisition Corp. II. This filing formalizes the significant equity position held by the reporting entity in the subject company.…more

    $10.29+0.00%vs prev close
    View filingShare

7 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 10.14Regular26.10.14 23:10
    #●●●

    Trading Resumed for IPO Security

    The trading halt for the newly listed IPO security has been lifted, allowing market activity to resume. Investors should monitor the stock for potential price volatility following the resumption.…more

    $10.29+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga